Location History:
- Freiburg, DE (1996 - 2004)
- Weimar-Gaberndorf, DE (2012)
Company Filing History:
5 out of 560 
1 out of 7 
1 out of 6,858 Years Active: 1996-2012
Title: The Innovative Contributions of Dirk Vetter
Introduction
Dirk Vetter is a prominent inventor based in Freiburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of methods and libraries that enhance the quality of hybridization signals in oligonucleotide arrays. With a total of seven patents to his name, Vetter's work has implications for pharmaceutical discovery and diagnostics.
Latest Patents
Dirk Vetter's latest patents include innovative methods for enzymatic discrimination enhancement and surface-bound double-stranded DNA. These methods focus on discriminating between fully complementary hybrids and those that differ by one or more base pairs. One embodiment of his invention provides methods of using nuclease treatment to improve the quality of hybridization signals on high-density oligonucleotide arrays. Another embodiment involves using ligation reactions to enhance these signals. Additionally, Vetter has developed libraries of unimolecular or intermolecular double-stranded oligonucleotides on a solid support, which are useful in screening biological samples for specific interactions with peptides, proteins, drugs, and RNA. His work also includes libraries of conformationally restricted probes that are beneficial in drug discovery and diagnostic procedures.
Career Highlights
Throughout his career, Dirk Vetter has worked with notable companies such as Affymetrix, Inc. and Ciba-Geigy Corporation. His experience in these organizations has allowed him to refine his expertise in biotechnology and contribute to significant advancements in the field.
Collaborations
Dirk Vetter has collaborated with esteemed colleagues, including David J. Lockhart and Martin Diggelmann. These partnerships have further enriched his research and development efforts.
Conclusion
Dirk Vetter's innovative work in biotechnology, particularly in the area of oligonucleotide arrays, has made a lasting impact on pharmaceutical discovery and diagnostics. His contributions continue to influence the field and pave the way for future advancements.